Mol Oncol. 2025 Jan;19(1):261. doi: 10.1002/1878-0261.13775. Epub 2024 Dec 3.
H. Zhang, T. Liu, S. Yi, L. Gu, and M. Zhou, "Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation," Molecular Oncology 9, no. 7 (2015): 1301-1311, https://doi.org/10.1016/j.molonc.2015.03.005. The above article, published online on 24 March 2015 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan; FEBS Press; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate image section duplications within the article (Figure 5B) and between this (Figures 3B and 4B) and another article published by the same group of authors in a different scientific context. The authors were unable to provide a satisfactory explanation and the original raw data, which has led the editors to lose confidence in the data presented. Therefore, the editors consider the conclusions substantially compromised and are retracting the paper.
张H、刘T、易S、顾L和周M，“用Mir - 375靶向MYCN扩增的神经母细胞瘤中的MYCN内部核糖体进入位点可抑制肿瘤生长并使肿瘤细胞对辐射敏感”，《分子肿瘤学》9卷，第7期（2015年）：1301 - 1311页，https://doi.org/10.1016/j.molonc.2015.03.005 。上述文章于2015年3月24日在威利在线图书馆（wileyonlinelibrary.com）在线发表，已由期刊主编凯文·瑞安、FEBS出版社和约翰·威利父子有限公司协商撤回。在对第三方提出的担忧进行调查后达成了撤回协议，调查发现文章内存在不适当的图像部分重复（图5B），以及本文（图3B和4B）与同一组作者在不同科学背景下发表的另一篇文章之间存在重复。作者无法提供令人满意的解释以及原始原始数据，这导致编辑们对所呈现的数据失去信心。因此，编辑们认为结论受到严重影响，现撤回该论文。
